Launch week offerEnds in00h00m00s

annual Promonthly Pro

Uwe Reuter

Charité - Universitätsmedizin Berlin

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (10)

Henrik Winther Schytz

DENMARK

View details

Hans-Christoph Diener

University of Duisburg-Essen Faculty of Medizin

GERMANY

View details

Andrea Harriott

Massachusetts General Hospital

UNITED STATES

View details

Philip Robert Holland

Reader

King’s College London

UNITED KINGDOM

View details

Maria Terhart

Charité - Universitätsmedizin Berlin

GERMANY

View details

Jan Versijpt

Vrije Universiteit Brussel

BELGIUM

View details

Margarita Sanchez Del Rio

Headache specialist

Clinica Universidad de Navarra

SPAIN

View details

Lucas Hendrik Overeem

Charité - Universitätsmedizin Berlin

GERMANY

View details

Arne May

Universität Hamburg

GERMANY

View details

Daniel Schulze

Charité - Universitätsmedizin Berlin

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Uwe Reuter

Research Interests

Make your next move.

Explore related searches

Articles (20)

What’s a migraine day? Towards a consensus definition for clinical care and research – a Delphi panel-based study

Sex-specific management of migraine a systematic review and consensus statement from the European Headache Federation (EHF)

Decoding the long-term safety of anti-CGRP (receptor) mAbs

Oxytocin receptor antagonism in migraine: a randomized, double-blind, placebo-controlled provocation study.

Comorbidities as risk factors for migraine onset: A systematic review and three-level meta-analysis.

Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives

Efficacy and safety of kinetic oscillation stimulation in the nasal cavity for the treatment of acute migraine attacks: A randomized, placebo-controlled, double-blind investigation

Erenumab for Chronic Cluster Headache: A Randomized Clinical Trial.

Raising the bar in migraine prevention: Toward freedom and optimal control

Treating episodic migraine with precision: the evolving landscape of targeted therapies driven by insights in disease biology

Early Improvements With Atogepant for the Preventive Treatment of Migraine

Consistency between headache diagnoses and ICHD-3 criteria across different levels of care

Characteristics of patients with cluster headache presenting to a tertiary headache center: A cross-sectional study

Changes in brainstem habituation during onabotulinumtoxinA treatment in chronic migraine: A prospective case-control study.

Differences in pharmacological migraine treatment across different levels of clinical headache care - a cross-sectional study.

Sequential use of OnabotulinumtoxinA and Erenumab in Chronic Migraine: Retrospective Real-World Report on Bidirectional Switching.

Sex hormone profiles in men with migraine: a cross-sectional, matched cohort study.

Sex-related disparities in migraine recognition and management: insights from a tertiary headache center cohort.

Erenumab versus topiramate: migraine‐related disability, impact and health‐related quality of life

Collaborators (10)

Henrik Winther Schytz

Hans-Christoph Diener

Andrea Harriott

Philip Robert Holland

Maria Terhart

Jan Versijpt

Margarita Sanchez Del Rio

Lucas Hendrik Overeem

Arne May

Daniel Schulze

Make your next move.